Besides the minor effects of myeloid-specific deletion of IRF4, the accelerated tumor growth in global IRF4-deficient mice demonstrates a central role of IRF4 in shaping the TME and anti-tumor immunity. The gene discussed is IRF4; the disease is neoplasm.